FBRX

Forte Biosciences, Inc.

Nasdaq · Pharmaceutical Preparations · EDGAR filings (CIK 1419041) · 4 signals · 0 setups · updated Aug 16, 2026

What the filings say Pressure ▼

The company says its prior financial statements should not be relied on; a restatement follows.

Radar 47 (elevated attention) · dilution pressure low · listing risk elevated · governance risk low · runway 31.7 mo · strongest signal: Restatement (non-reliance) (Jul 27, 2026)

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

47Radar · attention score (0–100)

35Dilution pressure · financing + balance sheet

49Listing risk · exchange standards

38Governance risk · reporting, auditor, going concern

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on FBRX

Alerts

One email the morning FBRX files anything that matches your rules (types, minimum score, setups).

12-month history

Every signal and setup for FBRX back a year, not just 30 days — see how the current setup built.

Full analyst notes

What we noticed, evidence with links, what could prove us wrong, red-team caveats.

Full screener + CSV

All 985 flagged companies, same-day, sortable and exportable.

Get Pro · $18.85/mo founding rate See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$49.6Mcash + short-term investments as of Jun 30, 2026

31.7 moestimated runway (4x latest quarterly operating cash burn)

$183.8Mstockholders' equity as of Jun 30, 2026

$157.0Mpublic float (10-K cover)

21.2Mshares outstanding as of Aug 7, 2026 · was 13.9M Mar 27, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

Date	Signal	Evidence	Score
Jul 27, 2026	▼ Restatement (non-reliance)	“nonreliance” language in 8-K (EX-2.1) filed 2026-07-27 filing	38
Jul 27, 2026	▼ Reverse split	“reverse split” language in 8-K (EX-2.1) filed 2026-07-27 filing	32
Jul 27, 2026	▼ Delisting language	“delisting notice” language in 8-K (EX-2.1) filed 2026-07-27 filing	32
Jun 30, 2026	▼ Share count +25%	Shares outstanding 13,885,668 (2026-03-27) -> 21,229,087 (2026-08-07), +53% filing	35

Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans